Gene · 3568
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging Therapeutic Strategies in Asthma: Advances in Treatment, Drug Delivery, Drug Adherence, and Disease Management. | Curr Allergy Asthma Rep | 2026 | 41790360 | PubTator, text mining | PubMed |
| Effects of Tezepelumab in "United Airway Disease" (Asthma and CRSwNP). | Case Rep Pulmonol | 2026 | 41788313 | PubTator, text mining | PubMed |
| Longitudinal observation of severe asthma comorbidities and oral corticosteroids use from SANI and ISAR registries. | World Allergy Organ J | 2026 | 41783626 | PubTator, text mining | PubMed |
| Treatment of Kimura disease with dupilumab: a case report and literature review. | Front Immunol | 2026 | 41777898 | PubTator, text mining | PubMed |
Significant Production of Serum and Mucosal Anti-Spike-IgA Antibodies After Vaccine-Encoded or SARS-CoV-2-Infection-Induced Spike-Exposures in Patients with Asthma Treated with Monoclonal Antibodies Compared to Conventional Therapy. | J Asthma Allergy | 2026 | 41773183 | PubTator, text mining | PubMed |
| DOMINICA protocol: A study of benralizumab for severe eosinophilic asthma in children. | Pediatr Allergy Immunol | 2026 | 41759040 | PubTator, text mining | PubMed |
| QX008N, an Anti-TSLP Monoclonal Antibody: Pharmacokinetics, Tolerability, and Immunogenicity in Healthy Chinese Subjects. | Clin Transl Sci | 2026 | 41757744 | PubTator, text mining | PubMed |
| Inhalation-Based Nanoparticle Drug Delivery Targeting the Diseased Lower Airways in Idiopathic Pulmonary Fibrosis. | Pharmaceutics | 2026 | 41754911 | PubTator, text mining | PubMed |
| Cytokines Associated with Activation of CD4+CD25+Foxp3+ T Regulatory Cells. | Int J Mol Sci | 2026 | 41752221 | PubTator, text mining | PubMed |
| Intra-subtype heterogeneity shapes treatment response in KMT2A-rearranged ALL across all age groups. | Hemasphere | 2026 | 41743263 | PubTator, text mining | PubMed |
| Exacerbations and Management of Asthma in Viral Lower Respiratory Tract Infections: The Significance of Immunoglobulin E. | Immun Inflamm Dis | 2026 | 41738365 | PubTator, text mining | PubMed |
| Beyond inhaled medications: precision medicine and biologic therapies targeting the IL-33/TSLP/type 2 axis in COPD. | Front Immunol | 2026 | 41727449 | PubTator, text mining | PubMed |
| The Intersection of m6A Methylation and Immune Response in PCOS: A Bioinformatics Perspective. | Immun Inflamm Dis | 2026 | 41725222 | PubTator, text mining | PubMed |
| Identification of circulatory neuro-related proteins in Parkinson's disease: an integrated genetic-proteomic-clinical study. | EBioMedicine | 2026 | 41724112 | PubTator, text mining | PubMed |
| IgE, anti-IgE therapy, and regulatory T cells: new paradigms in allergic inflammation. | Front Allergy | 2026 | 41717655 | PubTator, text mining | PubMed |
| Green Light for Response: Clinical Stratification of Response to Biologic Therapy in Severe Asthma. | J Asthma Allergy | 2026 | 41710132 | PubTator, text mining | PubMed |
| IL-5 CAR-T cell therapy induces effective remission in hypereosinophilic disorders. | J Hematol Oncol | 2026 | 41689037 | PubTator, text mining | PubMed |
| Systemic Treatments for Chronic Spontaneous Urticaria: Anti-IgE and Beyond. | J Allergy Clin Immunol Pract | 2026 | 41654334 | PubTator, text mining | PubMed |
| Novel Diagnostic Approaches for Eosinophilic Lung Diseases. | J Allergy Clin Immunol Pract | 2026 | 41651409 | PubTator, text mining | PubMed |
| Biologic therapies for severe pediatric asthma: efficacy, safety, and biomarker-guided selection. | Front Allergy | 2026 | 41640839 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3568/papers?page=4